Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

forbes.com - Gloria Haraito - Indian Billionaire Brothers' Mankind Pharma To Buy Bharat Serums For $1.6 Billion
Indian Billionaire Brothers' Mankind Pharma To Buy Bharat Serums For $1.6 Billion
Forbes

Mankind Pharma —owned by Indian billionaire brothers Ramesh and Rajeev Juneja — has agreed to buy Bharat Serums and Vaccines (BSV) for 136.3 billion rupees ($1.6 billion) from Boston-based private equity firm Advent International. The…

seekingalpha.com - Arundhati Sarkar - Poolbeg Pharma to voluntarily delist from OTCQB market (OTCQB:POLBF)
Poolbeg Pharma to voluntarily delist from OTCQB market (OTCQB:POLBF)
Seeking Alpha

UK-based Poolbeg Pharma (OTCQB:POLBF) on Friday said that it would voluntarily delist its ordinary shares from trading on the OTCQB market due to low trading volume and the associated administrative requirements. The company's last day of trading…

seekingalpha.com - Joshua Fineman - Mirum Pharma stock gains amid report of approach from Swedish Orphan Biovitrum
Mirum Pharma stock gains amid report of approach from Swedish Orphan Biovitrum
Seeking Alpha

Mirum Pharmaceuticals (NASDAQ: MIRM) quickly jumped 7% amid takeover speculation. Mirum (MIRM) has been approached by a possible acquisition by Swedish Orphan Biovitrum AB (OTCPK:BIOVF), according to a Street Insider report on Friday, which cited…

newswire.ca - Piramal Pharma Ltd - Piramal Pharma Limited Announces Consolidated Results for Q1FY25
Piramal Pharma Limited Announces Consolidated Results for Q1FY25
CNW

MUMBAI, India, July 26, 2024 /CNW/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the First Quarter (Q1) ended 30 June 2024.

newswire.ca - Innocan Pharma Corporation - Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
CNW

HERZLIYA, Israel and CALGARY, AB, July 26, 2024 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ('Innocan' or the 'Company'), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the…

firstpost.com - Vinamra Mathur - EXCLUSIVE | JioCinema's 'PILL' director Rajkumar Gupta on Riteish Deshmukh: 'Always admired his work, he's not just a star but...
EXCLUSIVE | JioCinema's 'PILL' director Rajkumar Gupta on Riteish Deshmukh: 'Always admired his work, he's not just a star but...
Firstpost

Rajkumar Gupta's PILL now streaming on JioCinema, introduces you to Prakash Chauhan, played by Riteish Deshmukh, who digs through the deep-set rot in the Indian pharmaceutical world. The series showcases the process through which a pill reaches an…

bizjournals.com - Ashley Portero - FAU researcher receives grant to rethink cancer treatment - South Florida Business Journal
FAU researcher receives grant to rethink cancer treatment - South Florida Business Journal
The Business Journals

An assistant professor at Florida Atlantic University received a $701,000 grant from Precess Medical Derivatives to personalize radiation therapy for cancer treatment. Wazir Muhammad, a principal investigator and professor at the university's…

dailymail.co.uk - J. Peterson For Dailymail.Com - Celebrity trainer Jillian Michaels declares she's 'uncancelable
Celebrity trainer Jillian Michaels declares she's 'uncancelable
Mail Online

Trainer's Keeping It Real podcast has joined Bill Maher's Club Random network 'We're taking on the subjects that people are afraid to deal with,' she said READ MORE: Jillian Michaels on why she moved away from California After surviving two decades…

thereporteronline.com - John Worthington - Almac Group celebrates 'topping out' of expansion project in Souderton
Almac Group celebrates 'topping out' of expansion project in Souderton
The Reporter

Almac Group marks the next phase of its 115,000 expansion project with a beam signing and 'topping out' ceremony. (Courtesy of Angeliki Lumpkin) SOUDERTON — Almac Group recently celebrated the company's Souderton expansion project with a…

rediff.com - PTI - Sensex back above 81K; Nifty surges 429 points
Sensex back above 81K; Nifty surges 429 points
Rediff.com

Benchmark Sensex rebounded by 1,293 points while broader Nifty shot up nearly 2 per cent to a record high on Friday, cutting short the five-day losing streak on heavy at lower levels and a rally in blue-chips like Reliance Industries. The 30-share…

comicbook.com - Nick Valdez - Common Side Effects First Look Released: Watch
Common Side Effects First Look Released: Watch
Comicbook.com

Common Side Effects is debuting its first episode as part of San Diego Comic-Con 2024 weekend, and with it Adult Swim has shared the first look clip for the new series! Adult Swim has been hitting screens with some of their most popular original…

seekingalpha.com - Dulan Lokuwithana - Pfizer, Merck bladder cancer drug endorsed in EU (NYSE:PFE)
Pfizer, Merck bladder cancer drug endorsed in EU (NYSE:PFE)
Seeking Alpha

Merck (NYSE: MRK) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its blockbuster anti-PD-1 therapy Keytruda in combination with Pfizer's (NYSE: PFE) antibody-drug conjugate, Padcev, for…

thehindu.com - Nifty-50 hits all time high, Sensex surges 1,233 points
Nifty-50 hits all time high, Sensex surges 1,233 points
The Hindu

Key benchmark stock indices on Friday gained about 1.7% following heavy buying in infrastructure and IT, Pharma stocks. BSE Sensex gained 1.62% or 1,293 points to hit 81,333 points, close to its all time high level. NSE Nifty-50 index rose 1.76% or…

adweek.com - Robert Klara - Pfizer's First CMO Drew Panayioutou to Depart
Pfizer's First CMO Drew Panayioutou to Depart
Adweek

With C-suite leaders from iconic brands keynoting sessions, leading workshops and attending networking events, Brandweek is the place to be for marketing innovation and problem-solving. Register to attend September 23–26 in Phoenix, Arizona.

seekingalpha.com - Dulan Lokuwithana - Bristol-Myers stock gains on Q2 beat (NYSE:BMY)
Bristol-Myers stock gains on Q2 beat (NYSE:BMY)
Seeking Alpha

Shares of Bristol-Myers Squibb (NYSE: BMY) traded higher in the premarket Friday after the pharma giant exceeded Street forecasts with its Q2 2024 financials and announced a Phase 3 trial win for its experimental antibody therapy, cendakimab.

Receive a Daily briefing on Pharma Industry News

Get Started